Li Xie

Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports

Jingtao Gao, W. Shu, Yuhong Liu, 2021, World journal of clinical cases.

Interferon-Gamma Release Assay Performance of Pleural Fluid and Peripheral Blood in Pleural Tuberculosis

Zongde Zhang, F. Du, M. Gao, 2013, PloS one.

Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study.

Ming-wu Li, Y. Pang, Jingtao Gao, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study

Jingtao Gao, W. Shu, Liang Li, 2022, Antimicrobial agents and chemotherapy.

Retrospective Analysis of 28 Cases of Tuberculosis in Pregnant Women in China

M. Gao, Liping Ma, Yan-hua Song, 2019, Scientific Reports.

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Ming-wu Li, Jichan Shi, Jingtao Gao, 2021, Infectious Diseases of Poverty.

Prospective Comparison of QFT-GIT and T-SPOT.TB Assays for Diagnosis of Active Tuberculosis

W. Sha, Zongde Zhang, F. Du, 2018, Scientific Reports.

Prospective Comparison of QFT-GIT and T-SPOT.TB Assays for Diagnosis of Active Tuberculosis

W. Sha, Zongde Zhang, F. Du, 2018, Scientific Reports.

[The in-vitro interferon-gamma release assay for the diagnosis of tuberculosis and Mycobacterium tuberculosis infections].

A. Xing, Chuan-Yuo Li, Wei-wei Gao, 2005, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

Low Doses of Rifampicin Used in New Tuberculosis Patients Correlated to Increased Frequency of Rifampicin-Resistance and Poorer Treatment Outcomes

Hong Zhang, Xiaomeng Wang, Yan Ma, 2015 .

Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

Ming-wu Li, W. Shu, Fengling Mi, 2024, BMC medicine.